Corcept Therapeutics Incorporated (CORT) Revenue & EPS Growth Rates 2026

Growth Analysis - CORT

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth12.79%

5Y CAGR16.56%

10Y CAGR31.23%

Net Income

1Y Growth-28.68%

5Y CAGR-1.23%

10Y CAGRN/A

EPS

1Y Growth-29.63%

5Y CAGR0.64%

10Y CAGRN/A

EBIT

1Y Growth-51.47%

5Y CAGR-12.31%

10Y CAGRN/A

EBITDA

1Y Growth-50.09%

5Y CAGR-12.12%

10Y CAGRN/A

Capex

1Y Growth-90.29%

5Y CAGR-29.80%

10Y CAGR28.64%

Equity

1Y Growth-4.68%

5Y CAGR4.36%

10Y CAGR42.70%

Cash Flow

1Y Growth-28.31%

5Y CAGR-1.35%

10Y CAGR46.44%

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	12.8%	25.6%	23.7%	16.6%	31.2%	N/A	N/A	N/A
FY 2024 Dec 31, 2024	39.9%	29.6%	22.6%	17.1%	38.2%	95.5%	N/A	N/A
FY 2023 Dec 31, 2023	20.0%	14.8%	10.9%	13.9%	46.8%	67.6%	N/A	N/A
FY 2022 Dec 31, 2022	9.8%	6.6%	9.5%	20.3%	61.6%	56.6%	N/A	N/A
FY 2021 Dec 31, 2021	3.4%	9.3%	13.4%	35.1%	N/A	60.8%	N/A	N/A
FY 2020 Dec 31, 2020	15.5%	18.7%	30.5%	47.7%	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	22.0%	38.7%	55.6%	63.1%	152.6%	N/A	N/A	N/A
FY 2018 Dec 31, 2018	57.8%	75.8%	71.0%	89.2%	103.2%	N/A	N/A	N/A
FY 2017 Dec 31, 2017	95.8%	77.9%	81.7%	117.0%	78.6%	N/A	N/A	N/A
FY 2016 Dec 31, 2016	61.7%	75.0%	98.8%	N/A	75.5%	N/A	N/A	N/A
FY 2015 Dec 31, 2015	89.4%	120.3%	147.7%	N/A	N/A	N/A	N/A	N/A
FY 2014 Dec 31, 2014	156.4%	183.4%	N/A	291.1%	N/A	N/A	N/A	N/A
FY 2013 Dec 31, 2013	213.2%	N/A	N/A	118.3%	N/A	N/A	N/A	N/A
FY 2012 Dec 31, 2012	N/A	N/A	384.9%	47.0%	N/A	N/A	N/A	N/A
FY 2011 Dec 31, 2011	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2010 Dec 31, 2010	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2009 Dec 31, 2009	-86.1%	-75.5%	-53.8%	N/A	N/A	N/A	N/A	N/A
FY 2008 Dec 31, 2008	-56.6%	-15.7%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2007 Dec 31, 2007	63.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2006 Dec 31, 2006	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2005 Dec 31, 2005	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2004 Dec 31, 2004	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2003 Dec 31, 2003	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2002 Dec 31, 2002	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2001 Dec 31, 2001	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - CORT

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Corcept Therapeutics Incorporated

Compare with peers

Explore

Growth Analysis - CORT

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Corcept Therapeutics Incorporated

Compare with peers

Explore